These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Multiple fixed drug eruption caused by ropinirole in a patient with Parkinson's disease. Sasaki-Saito N; Sawada Y; Ohmori S; Omoto D; Haruyama S; Yoshioka M; Nishio D; Nakamura M Allergol Int; 2016 Apr; 65(2):221-222. PubMed ID: 26790807 [No Abstract] [Full Text] [Related]
63. Suicide without depression after withdrawal of a dopamine agonist in a patient with Parkinson's disease. Flament M; Loas G; Godefroy O; Krystkowiak P J Neuropsychiatry Clin Neurosci; 2011; 23(4):E32. PubMed ID: 22231340 [No Abstract] [Full Text] [Related]
64. Isolated tactile hallucination in a patient with Parkinson's disease: Quetiapine conquers the snakes and stones. Lenka A; Reddy YCJ; Pal PK Asian J Psychiatr; 2018 Jun; 35():34-35. PubMed ID: 29754101 [No Abstract] [Full Text] [Related]
65. [Depression in Parkinson's disease]. Murata M; Okamoto T Nihon Ronen Igakkai Zasshi; 2013; 50(6):752-4. PubMed ID: 24622217 [TBL] [Abstract][Full Text] [Related]
66. The Importance of Cross-Disciplinary Research: A Commentary on "Brainstem Pathologies Correlate With Depression and Psychosis in Parkinson's Disease". Schneider RB; Richard IH Am J Geriatr Psychiatry; 2021 Sep; 29(9):969-971. PubMed ID: 33526370 [No Abstract] [Full Text] [Related]
67. Are dopamine antagonists a risk factor for breast cancer? An answer from Parkinson's disease. Lalonde FM; Myslobodsky M Breast; 2003 Aug; 12(4):280-2. PubMed ID: 14659314 [TBL] [Abstract][Full Text] [Related]
68. Dopamine Dysregulation Syndrome in Parkinson Disease and Remission After Treatment With Aripiprazole. Al-Qassabi A; Al Sinani A J Clin Psychopharmacol; 2022 Mar-Apr 01; 42(2):209-210. PubMed ID: 35135978 [No Abstract] [Full Text] [Related]
71. Antipsychotics and Parkinson's Disease: A Troubling Mix. Sr Care Pharm; 2023 Apr; 38(4):120-121. PubMed ID: 36949563 [No Abstract] [Full Text] [Related]
72. Fandy TE Sr Care Pharm; 2023 Apr; 38(4):122. PubMed ID: 36949559 [No Abstract] [Full Text] [Related]
73. Quetiapine as treatment for dopaminergic-induced dyskinesias in Parkinson's disease. Baron MS; Dalton WB Mov Disord; 2003 Oct; 18(10):1208-9. PubMed ID: 14534933 [No Abstract] [Full Text] [Related]
74. Quetiapine: novel uses in the treatment of depressive and anxiety disorders. Ravindran AV; Al-Subaie A; Abraham G Expert Opin Investig Drugs; 2010 Oct; 19(10):1187-204. PubMed ID: 20795889 [TBL] [Abstract][Full Text] [Related]
75. Remission of acute psychotic anxious depression in a patient with Parkinson's disease after treatment with quetiapine. Link S; Paulus W; Bandelow B Mov Disord; 2009 Dec; 24(16):2431-2. PubMed ID: 19890998 [No Abstract] [Full Text] [Related]
76. Akathisia as a side effect of antipsychotic treatment with quetiapine in a patient with Parkinson's disease. Prueter C; Habermeyer B; Norra C; Kosinski CM Mov Disord; 2003 Jun; 18(6):712-3. PubMed ID: 12784279 [TBL] [Abstract][Full Text] [Related]
77. Rhabdomyolysis after low-dose quetiapine in a patient with Parkinson's disease with drug-induced psychosis: a case report. Stephani C; Trenkwalder C Mov Disord; 2010 Apr; 25(6):790-1. PubMed ID: 20198646 [No Abstract] [Full Text] [Related]